Auckland biotechnology company Neuren Pharmaceuticals’ co-operation with the US Army is beginning to bear fruit, with the pair applying for a joint patent for Neuren’s brain injury drug.
Auckland biotechnology company Neuren Pharmaceuticals’ co-operation with the US Army is beginning to bear fruit, with the pair applying for a joint patent for Neuren’s brain injury drug.
